Nemes Rush Group
INSM icon

Nemes Rush Group’s Insmed INSM Stock Holding History

Nemes Rush Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$228 Hold
2
– – ﹤0.01% 917
2026
Q2 		$213 Hold
2
– – ﹤0.01% 939
2026
Q1 		$327 Sell
2
-2
-50% -$307 ﹤0.01% 905
2025
Q4 		$696 Buy
+4
New +$730 ﹤0.01% 851
2025
Q3 		– Sell
-3
Closed -$302 – 710
2025
Q2 		$302 Buy
+3
New +$229 ﹤0.01% 702

Other funds holding INSM

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Nemes Rush Group's INSM Position: Q3 2026 in Review

Nemes Rush Group held its Insmed (INSM) position steady in Q3 2026 at 2 shares worth $228. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Nemes Rush Group first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $696 in Q4 2025. 304 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Nemes Rush Group held 2 shares of Insmed worth $228 as of Q3 2026.
  • Nemes Rush Group left its Insmed share count unchanged in Q3 2026.
  • Insmed made up ﹤0.01% of Nemes Rush Group's portfolio in Q3 2026, its #917 holding.
  • Nemes Rush Group first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • Nemes Rush Group's Insmed position peaked at $696 in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Nemes Rush Group's 13F filing for Q3 2026, filed 4 Nov 2026.